Book contents
- Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies
- Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies
- Copyright page
- Contents
- Contributors
- Preface
- Abbreviations
- 1 Flow Cytometry in Clinical Haematopathology: Basic Principles and Data Analysis of Multiparameter Data Sets
- 2 Antigens
- 3 Flow Cytometry of Normal Blood, Bone Marrow and Lymphatic Tissue
- 4 Reactive Conditions and Other Diseases Where Flow Cytometric Findings May Mimic Haematological Malignancies
- 5 Examples of Immunophenotypic Features in Various Categories of Acute Leukaemia
- 6 Acute Lymphoid Leukaemias (ALL) and Minimal Residual Disease in ALL
- 7 Immunophenotyping of Mature B-Cell Lymphomas
- 8 Plasma Cell Myeloma and Related Disorders
- 9 Mature T-Cell Neoplasms and Natural Killer-Cell Malignancies
- 10 Flow Cytometric Diagnosis of Hodgkin's Lymphoma in Lymph Nodes
- 11 Minimal Residual Disease in Acute Myeloid Leukaemia
- 12 Ambiguous Lineage and Mixed Phenotype Acute Leukaemia
- 13 Flow Cytometry in Myelodysplastic Syndromes
- 14 Future Applications of Flow Cytometry and Related Techniques
- Index
- References
10 - Flow Cytometric Diagnosis of Hodgkin's Lymphoma in Lymph Nodes
Published online by Cambridge University Press: 01 February 2018
Book contents
- Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies
- Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies
- Copyright page
- Contents
- Contributors
- Preface
- Abbreviations
- 1 Flow Cytometry in Clinical Haematopathology: Basic Principles and Data Analysis of Multiparameter Data Sets
- 2 Antigens
- 3 Flow Cytometry of Normal Blood, Bone Marrow and Lymphatic Tissue
- 4 Reactive Conditions and Other Diseases Where Flow Cytometric Findings May Mimic Haematological Malignancies
- 5 Examples of Immunophenotypic Features in Various Categories of Acute Leukaemia
- 6 Acute Lymphoid Leukaemias (ALL) and Minimal Residual Disease in ALL
- 7 Immunophenotyping of Mature B-Cell Lymphomas
- 8 Plasma Cell Myeloma and Related Disorders
- 9 Mature T-Cell Neoplasms and Natural Killer-Cell Malignancies
- 10 Flow Cytometric Diagnosis of Hodgkin's Lymphoma in Lymph Nodes
- 11 Minimal Residual Disease in Acute Myeloid Leukaemia
- 12 Ambiguous Lineage and Mixed Phenotype Acute Leukaemia
- 13 Flow Cytometry in Myelodysplastic Syndromes
- 14 Future Applications of Flow Cytometry and Related Techniques
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2018
References
Kuppers, R., Engert, A., and Hansmann, M.L.. Hodgkin lymphoma. J Clin Invest, 122 (2012), 3439–47.CrossRefGoogle ScholarPubMed
Swerdlow, S., ed. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. (2008, IARC press, Lyon, France).Google Scholar
Hudnall, S.D., Betancourt, E., Barnhart, E., et al., Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia. Cytometry B Clin Cytom, 74 (2008), 1–8.CrossRefGoogle ScholarPubMed
Fromm, J.R., Kussick, S.J., and Wood, B.L.. Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting. Am J Clin Pathol, 126 (2006), 764–80.CrossRefGoogle ScholarPubMed
Fromm, J.R., Sabath, D.E., and Wood, B.L., Diagnostic usefulness of flow cytometry for immunophenotyping classical Hodgkin lymphoma. Am J Clin Pathol, 136 (2011), 157–8.CrossRefGoogle ScholarPubMed
Fromm, J.R., Thomas, A., and Wood, B.L.. Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity. Am J Clin Pathol, 131 (2009), 322–32.CrossRefGoogle ScholarPubMed
Fromm, J.R. and Wood, B.L.. A six-color flow cytometry assay for immunophenotyping classical Hodgkin lymphoma in lymph nodes. Am J Clin Pathol, 141 (2014), 388–96.CrossRefGoogle ScholarPubMed
Irsch, J., Nitsch, S., Hansmann, M.L., et al. Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues. Proc Natl Acad Sci U S A, 95 (1998), 10117–22.CrossRefGoogle ScholarPubMed
Carbone, A. and Gloghini, A.. The role of current and new discriminating markers in the immunodiagnosis of Hodgkin's disease and other phenotypically related lymphomas. Pathologica, 88 (1996), 169–74.Google ScholarPubMed
Kim, L.H., Eow, G.I., Peh, S.C., et al. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma. Pathology, 35 (2003), 428–35.CrossRefGoogle ScholarPubMed
Masir, N., Marafioti, T., Jones, M., et al., Loss of CD19 expression in B-cell neoplasms. Histopathology, 48 (2006), 239–46.CrossRefGoogle ScholarPubMed
Tedoldi, S., Mottok, A., Ying, J., et al., Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. J Pathol, 213 (2007), 429–40.CrossRefGoogle ScholarPubMed
Banchereau, J., Bazan, F., Blanchard, D., et al., The CD40 antigen and its ligand. Annu Rev Immunol, 12 (1994), 881–922.CrossRefGoogle ScholarPubMed
Dorreen, M.S., Habeshaw, J.A., Stansfeld, A.G., et al. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease, an immunohistological study. Br J Cancer, 49 (1984), 465–76.CrossRefGoogle ScholarPubMed
Peter, M.E., Budd, R.C., Desbarats, J., et al., The CD95 receptor, apoptosis revisited. Cell, 129 (2007), 447–50.CrossRefGoogle ScholarPubMed
Fromm, J.R. and Wood, B.L., Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting. Methods, 57 (2012), 368–75.CrossRefGoogle ScholarPubMed
Wu, D., Wood, B.L. and Fromm, J.R., Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma, in Lymphoma, Methods and Protocols, Methods in Molecular Biology, Kuppers, R., Editor. (2013, Berlin: Springer Science), 1–21.Google Scholar
Carbone, A., Gloghini, A., Gattei, V., et al. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood, 85 (1995), 780–9.CrossRefGoogle ScholarPubMed
Kesler, M.V., Paranjape, G.S., Asplund, S.L., et al., Anaplastic large cell lymphoma, a flow cytometric analysis of 29 cases. Am J Clin Pathol, 128 (2007), 314–22.CrossRefGoogle ScholarPubMed
Segal, G.H., Kjeldsberg, C.R., Smith, G.P., et al. CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases. Am J Clin Pathol, 102 (1994), 292–8.CrossRefGoogle ScholarPubMed
Barry, T.S., Jaffe, E.S., Sorbara, L., et al. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol, 27 (2003), 1513–22.CrossRefGoogle ScholarPubMed
Quintanilla-Martinez, L., Fend, F., Moguel, L.R., et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol, 23 (1999), 1233–40.CrossRefGoogle Scholar
Kanzler, H., Küppers, R., Helmes, S., et al. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones, potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood, 95 (2000), 1023–31.CrossRefGoogle ScholarPubMed
Momose, H., Jaffe, E.S., Shin, S.S., et al., Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol, 16 (1992), 859–67.CrossRefGoogle ScholarPubMed
Hernandez, O., Oweity, T. and Ibrahim, S., Is an increase in CD4/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph node FNAs with increased CD4/CD8 ratio. Cytojournal, 2 (2005), 14.CrossRefGoogle ScholarPubMed
Martin, J.M. and Warnke, R.A.. A quantitative comparison of T-cell subsets in Hodgkin's disease and reactive hyperplasia. Frozen section immunohistochemistry. Cancer, 53 (1984), 2450–5.Google ScholarPubMed
Bosler, D.S., Douglas-Nikitin, V.K., Harris, V.N. et al. Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma. Cytometry B Clin Cytom, 74 (2008), 227–35.Google Scholar
Fromm, J.R., Thomas, A. and Wood, B.L.. Increased expression of T cell antigens on T cells in classical Hodgkin lymphoma. Cytometry B Clin Cytom, 78 (2010), 387–8.Google Scholar
Seegmiller, A.C., Karandikar, N.J., Kroft, S.H. et al. Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes. Cytometry B Clin Cytom, 76 (2009), 169–74.Google ScholarPubMed
Rahemtullah, A., Harris, N.L., Dorn, M.E. et al. Beyond the lymphocyte predominant cell, CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma. Leuk Lymphoma, 49 (2008), 1870–8.CrossRefGoogle Scholar
Rahemtullah, A., Reichard, K.K., Preffer, F.I. et al. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J Clin Pathol, 126 (2006), 805–14.CrossRefGoogle ScholarPubMed
Steidl, C., Lee, T., Shah, S.P. et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med, 362 (2010), 875–85.CrossRefGoogle ScholarPubMed
Portlock, C.S., Donnelly, G.B., Qin, J., et al., Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol, 125 (2004), 701–8.CrossRefGoogle ScholarPubMed
Tzankov, A., Krugmann, J., Fend, F., et al. Prognostic significance of CD20 expression in classical Hodgkin lymphoma, a clinicopathological study of 119 cases. Clin Cancer Res, 9 (2003), 1381–6.Google ScholarPubMed
Oudejans, J.J., Jiwa, N.M., Kummer, J.A., et al. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood, 89 (1997), 1376–82.CrossRefGoogle Scholar
Sup, S.J., Alemañy, C.A., Pohlman, B., et al., Expression of bcl-2 in classical Hodgkin's lymphoma, an independent predictor of poor outcome. J Clin Oncol, 23 (2005), 3773–9.CrossRefGoogle ScholarPubMed
Chetaille, B., Bertucci, F., Finetti, P., et al., Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood, 113 (2009), 2765–75.CrossRefGoogle ScholarPubMed
Hopken, U.E., Foss, H.D., Meyer, D., et al. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood, 99 (2002), 1109–16.CrossRefGoogle Scholar
Armand, P., Shipp, M.A., Ribrag, V., et al., Programmed death-1 lockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure. J Clin Oncol, (2016). pii: JCO673467.Google Scholar
Tzankov, A., Zimpfer, A., Lugli, A., et al. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1. J Pathol, 199 (2003), 201–7.CrossRefGoogle ScholarPubMed
Fromm, J.R., Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma. Cytometry B Clin Cytom, 80 (2011), 91–9.Google ScholarPubMed